Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
3.680
+0.310 (9.20%)
At close: May 12, 2025, 4:00 PM
3.500
-0.180 (-4.89%)
After-hours: May 12, 2025, 5:15 PM EDT
Pulmonx Revenue
Pulmonx had revenue of $22.54M in the quarter ending March 31, 2025, with 19.54% growth. This brings the company's revenue in the last twelve months to $87.47M, up 19.84% year-over-year. In the year 2024, Pulmonx had annual revenue of $83.79M with 22.01% growth.
Revenue (ttm)
$87.47M
Revenue Growth
+19.84%
P/S Ratio
1.66
Revenue / Employee
$300,595
Employees
291
Market Cap
148.15M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 89.33B |
Merck & Co. | 63.92B |
AbbVie | 57.37B |
AstraZeneca | 54.98B |
Novartis AG | 53.22B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
LUNG News
- 11 days ago - Pulmonx to Present at the Bank of America Securities 2025 Health Care Conference - GlobeNewsWire
- 12 days ago - Pulmonx Corporation (LUNG) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 12 days ago - Pulmonx Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - EDAP Appoints Glen French to Board of Directors - GlobeNewsWire
- 2 months ago - Top 3 Health Care Stocks You May Want To Dump In February - Benzinga
- 2 months ago - Pulmonx Corporation (LUNG) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results - GlobeNewsWire
- 3 months ago - Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day - GlobeNewsWire